BCG vaccination-induced long-lasting control of Mycobacterium tuberculosis correlates with the accumulation of a novel population of CD4+IL-17+TNF+IL-2+ T cells

Mycobacterium bovis Bacille Calmette-Guerin (BCG) is the only vaccine in use to prevent Mycobacterium tuberculosis (Mtb) infection. Here we analyzed the protective efficacy of BCG against Mtb challenges 21 or 120 days after vaccination. Only after 120 days post-vaccination were mice able to efficien...

ver descrição completa

Detalhes bibliográficos
Autor principal: Cruz, Andrea Patrícia Ribeiro (author)
Outros Autores: Torrado, Egídio (author), Carmona, Jenny (author), Fraga, Alexandra G. (author), Costa, Patrício Soares (author), Rodrigues, Fernando (author), Appelberg, Rui (author), Neves, Margarida Correia (author), Cooper, Andrea M. (author), Saraiva, Margarida (author), Pedrosa, Jorge (author), Castro, António G. (author)
Formato: article
Idioma:eng
Publicado em: 2015
Assuntos:
Texto completo:http://hdl.handle.net/1822/32920
País:Portugal
Oai:oai:repositorium.sdum.uminho.pt:1822/32920